ArticleTranslational lung cancer research2019
Quantitative features of dual-energy spectral computed tomography for solid lung adenocarcinoma with
Article in Translational lung cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 15 citations in OpenAlex.
- Systematic review of spectral computed tomography quantitative parameters for predictingQuantitative imaging in medicine and surgery · 2026Review
- Identification of PD-L1 Expression in Resectable NSCLC using Interpretable Machine Learning Model Based on Spectral CTCurrent medical imaging · 2025Article
- Enhancing the prediction ofTranslational lung cancer research · 2024Article
- Dual-energy CT-based radiomics in predicting EGFR mutation status non-invasively in lung adenocarcinoma.Heliyon · 2024Article
- The new fast kilovoltage-switching dual-energy computed tomography for measuring bone mineral density.Quantitative imaging in medicine and surgery · 2023Article
- Radiomics/Radiogenomics in Lung Cancer: Basic Principles and Initial Clinical Results.Cancers · 2022Review
- Application of Dual-Energy Spectral Computed Tomography in Bone Mineral Density Measurement: Phantom and Clinical Research.International journal of general medicine · 2022Article
- Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer.Quantitative imaging in medicine and surgery · 2021Article
- Epidermal growth factor receptor mutations in lung adenocarcinoma: associations between dual-energy spectral CT measurements and histologic results.Journal of cancer research and clinical oncology · 2021Article
- Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.Cancer imaging : the official publication of the International Cancer Imaging Society · 2021Article
- Dual-energy computed tomography for pre-surgical identification of adenocarcinoma subtypes.Translational lung cancer research · 2020Article
- Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers.OncoTargets and therapy · 2020Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe present work aimed to evaluate radio-genomic associations of quantitative parameters obtained by dual-energy spectral computed tomography (DESCT) for solid lung adenocarcinoma with epidermal growth factor receptor (
methodsNinety-six cases of solid lung cancer were selected and assessed for
resultsThe positive rates were 51.0% (49/96) for
conclusionsQuantitative analysis of DESCT could help detect solid lung adenocarcinoma harboring
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.